Analystreport

Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at UBS Group AG from $67.00 to $61.00.

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview